MedPath

A clinical trial to compare the rise in hemoglobin and serum ferritin levels after giving either intravenous iron sucrose or oral ferrous ascorbate to anemic pregnant women.

Not Applicable
Completed
Conditions
Health Condition 1: null- Iron Deficiency Anemia in pregnancy.
Registration Number
CTRI/2010/091/001290
Lead Sponsor
Dr Deeba Shafi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Pregnant women between 28 and 37 weeks of gestation.

hemoglobin between 6 and 10gm%

iron deficiency anemia.

Exclusion Criteria

Anemia from cause other than iron deficiency.
Multiple pregnancy
History of previous blood transfusion.
History of hematological disease.
Risk of preterm labour.
Intolerance to iron derivatives.
Recent administration of iron.
Current usage of iron supplements

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
increase in hemoglobin in g/dlTimepoint: increase in hemoglobin at 2weeks,4 weeks and at 6 weeks.
Secondary Outcome Measures
NameTimeMethod
Increse in serum ferritin levels from baseline.Timepoint: increase at 2 weeks, 4weeks an at 6 weeks.
© Copyright 2025. All Rights Reserved by MedPath